Study guide

1.3 Measures of Association & Diagnostic Accuracy

USMLE Step 3 Exam

Track your progress as you read

Finished sections get a check mark.

1 Foundations - Biostatistics & Study Design

1.1 Study Designs & Clinical Trials 1.2 Hypothesis Testing & Statistical Significance 1.3 Measures of Association & Diagnostic Accuracy

2 Foundations - Epidemiology & Literature Interpretation

Section 2.1: Epidemiology & Risk Measures Section 2.2: Interpretation of Medical Literature & Ads Section 2.3: Preventive Medicine & Screening Guidelines

3 Foundations - Ethics & Communication

3.1 Medical Ethics & Patient Autonomy 3.2 Professionalism & Communication Skills 3.3 Legal Medicine & Informed Consent

4 Foundations - Patient Safety & Systems

Section 4.1: Patient Safety & Error Reduction Section 4.2: Quality Improvement & Systems-Based Practice Section 4.3: Healthcare Delivery Systems & Transitions of Care

5 Cardiovascular Management

5.1 Ischemic Heart Disease & Myocardial Infarction 5.2 Heart Failure & Cardiomyopathies 5.3 Arrhythmias & Conduction System Disorders 5.4 Vascular Diseases & Hypertension Management

6 Respiratory Management

Section 6.1: Obstructive Lung Diseases Section 6.2: Restrictive & Interstitial Lung Diseases Section 6.3: Infectious Pulmonary Diseases Section 6.4: Pulmonary Vascular & Pleural Diseases

7 Gastrointestinal & Hepatic Management

Esophageal & Gastric Disorders Intestinal & Colorectal Disorders Hepatic, Biliary, & Pancreatic Diseases Nutritional & Malabsorptive Syndromes

8 Renal, Urinary, & Endocrine Management

Section 8.1: Acute Kidney Injury & Chronic Kidney Disease Section 8.2: Fluid, Electrolyte, & Acid-Base Disorders Section 8.3: Diabetes Mellitus & Metabolic Syndrome Section 8.4: Thyroid, Adrenal, & Pituitary Disorders

9 Neurology, Special Senses, & Behavioral Health

9.1 Cerebrovascular Disease & Stroke 9.2 Neurodegenerative & Demyelinating Disorders 9.3 Psychiatric Emergencies & Substance Use Disorders 9.4 Common Mood, Anxiety, & Psychotic Disorders

10 Obstetrics & Gynecology

10.1 Antepartum Care & Pregnancy Complications 10.2 Intrapartum Management & Postpartum Care 10.3 Gynecology & Breast Disorders

11 Pediatrics, Human Development, & Multisystem Care

11.1 Normal Development & Childhood Immunizations 11.2 Common Pediatric & Neonatal Illnesses 11.3 Multisystem & Rheumatologic Diseases

12 Skin, Musculoskeletal, & CCS Case Management

Section 12.1: Common Dermatologic Presentations Section 12.2: Acute & Chronic Musculoskeletal Injuries Section 12.3: Computer-Based Case Simulations (CCS) Strategy

1.3 Measures of Association & Diagnostic Accuracy

Key Takeaways Explain This Topic AI

Relative risk compares disease incidence in exposed vs. unexposed groups in cohort studies, while odds ratio compares exposure odds in case-control studies.

The rare disease assumption states that when disease prevalence is low (typically under 5%), the odds ratio closely approximates the relative risk.

Sensitivity (SNOUT) rules out disease when negative, whereas specificity (SPIN) rules in disease when positive; both are intrinsic test properties unaffected by prevalence.

Positive predictive value increases and negative predictive value decreases as the disease prevalence in the tested population increases.

Likelihood ratios combine sensitivity and specificity to modify pre-test odds to post-test odds, making them clinically superior and independent of prevalence.

Last updated: July 2026

Measures of Association & Diagnostic Accuracy

In clinical practice, physicians must continuously evaluate the strength of associations between risk factors and diseases, as well as the performance of diagnostic tests. Mastering the calculations and clinical applications of measures of association, predictive values, likelihood ratios, and receiver operating characteristic curves is essential for clinical decision-making and is a core focus of the USMLE Step 3.

Measures of Association

Measures of association quantify the relationship between an exposure and an outcome. The choice of metric depends on the study design.

Relative Risk (RR)

Relative Risk (also known as the risk ratio) is used in prospective study designs, such as cohort studies and randomized controlled trials, where the incidence of disease can be directly measured. Relative Risk (RR) = Incidence of disease in exposed group Incidence of disease in unexposed group = a / ( a + b ) c / ( c + d ) \text{Relative Risk (RR)} = \frac{\text{Incidence of disease in exposed group}}{\text{Incidence of disease in unexposed group}} = \frac{a / (a + b)}{c / (c + d)} Relative Risk (RR) = Incidence of disease in unexposed group Incidence of disease in exposed group ​ = c / ( c + d ) a / ( a + b ) ​

Interpretation:

RR = 1 \text{RR} = 1 RR = 1 : No association.

RR > 1 \text{RR} > 1 RR > 1 : Increased risk of outcome in the exposed group.

RR < 1 \text{RR} < 1 RR < 1 : Decreased risk (protective effect) in the exposed group.

Example: Consider a cohort where 10% of exposed vs. 2% of unexposed develop an outcome; the Relative Risk is 10%/2% = 5.0.

Odds Ratio (OR)

The Odds Ratio is typically used in case-control studies, where the incidence of disease cannot be directly calculated because the proportion of cases and controls is determined by the investigator. It compares the odds of exposure among the cases to the odds of exposure among the controls. Odds Ratio (OR) = Odds of exposure in cases Odds of exposure in controls = a / c b / d = a d b c \text{Odds Ratio (OR)} = \frac{\text{Odds of exposure in cases}}{\text{Odds of exposure in controls}} = \frac{a / c}{b / d} = \frac{ad}{bc} Odds Ratio (OR) = Odds of exposure in controls Odds of exposure in cases ​ = b / d a / c ​ = b c a d ​

The Rare Disease Assumption: When a disease is rare in the population (typically prevalence < 5 % < 5\% < 5% ), the odds ratio closely approximates the relative risk. This allows researchers to use case-control studies to draw conclusions about relative risk.

Example: For an OR, if exposure odds are 4 in cases and 0.125 in controls, the Odds Ratio is 4/0.125 = 32.0.

Diagnostic Accuracy and the 2x2 Table

Diagnostic tests are evaluated using a standard 2x2 table comparing test results against a gold standard reference diagnosis.

  • Test Result \ Disease Status Disease Present Disease Absent
  • Test Positive True Positive (TP) False Positive (FP)
  • Test Negative False Negative (FN) True Negative (TN)
  • Sensitivity

Sensitivity is the probability that the test is positive in a patient who actually has the disease. Sensitivity = TP TP + FN \text{Sensitivity} = \frac{\text{TP}}{\text{TP} + \text{FN}} Sensitivity = TP + FN TP ​

Clinical Utility: High-sensitivity tests are used for screening. A negative result in a highly sensitive test helps rule out the disease (remember the mnemonic SNOUT : S ensitivity rules OUT ).

Specificity

Specificity is the probability that the test is negative in a patient who does not have the disease. Specificity = TN TN + FP \text{Specificity} = \frac{\text{TN}}{\text{TN} + \text{FP}} Specificity = TN + FP TN ​

Clinical Utility: High-specificity tests are used for confirmation. A positive result in a highly specific test helps rule in the disease (remember the mnemonic SPIN : SP ecificity rules IN ).

Predictive Values and the Influence of Prevalence

Unlike sensitivity and specificity, which are intrinsic, predictive values depend heavily on disease prevalence in the tested population.

Positive Predictive Value (PPV): The probability that a patient actually has the disease given a positive test result. PPV = TP TP + FP \text{PPV} = \frac{\text{TP}}{\text{TP} + \text{FP}} PPV = TP + FP TP ​

Negative Predictive Value (NPV): The probability that a patient does not have the disease given a negative test result. NPV = TN TN + FN \text{NPV} = \frac{\text{TN}}{\text{TN} + \text{FN}} NPV = TN + FN TN ​

Prevalence Effects:

As disease prevalence increases , the PPV increases (because there are more true positives and fewer false positives in the population), while the NPV decreases .

As disease prevalence decreases , the PPV decreases (even a highly specific test will yield many false positives when the disease is rare), while the NPV increases .

Likelihood Ratios (LRs)

Likelihood Ratios combine sensitivity and specificity into a single measure that is independent of disease prevalence. They indicate how much a test result shifts the probability of having the disease from the pre-test probability to the post-test probability.

Positive Likelihood Ratio ( LR + \text{LR}^+ LR + ): Indicates how much the odds of disease increase when the test is positive. LR + = Sensitivity 1 − Specificity \text{LR}^+ = \frac{\text{Sensitivity}}{1 - \text{Specificity}} LR + = 1 − Specificity Sensitivity ​ An LR + > 10 \text{LR}^+ > 10 LR + > 10 represents a strong diagnostic test that significantly increases the probability of disease.

Negative Likelihood Ratio ( LR − \text{LR}^- LR − ): Indicates how much the odds of disease decrease when the test is negative. LR − = 1 − Sensitivity Specificity \text{LR}^- = \frac{1 - \text{Sensitivity}}{\text{Specificity}} LR − = Specificity 1 − Sensitivity ​ An LR − < 0.1 \text{LR}^- < 0.1 LR − < 0.1 represents a strong test that significantly decreases the probability of disease.

Clinical Application: Likelihood ratios are clinically superior to predictive values because they can be applied directly to a patient's individual pre-test probability to calculate post-test probability using the formula: Pre-test Odds × Likelihood Ratio = Post-test Odds \text{Pre-test Odds} \times \text{Likelihood Ratio} = \text{Post-test Odds} Pre-test Odds × Likelihood Ratio = Post-test Odds . For example, if a patient has a 20% pre-test probability of coronary artery disease (pre-test odds = 0.25) and undergoes a stress test with an LR + \text{LR}^+ LR + of 8.0, their post-test odds become 0.25 × 8.0 = 2.0 0.25 \times 8.0 = 2.0 0.25 × 8.0 = 2.0 , which corresponds to a post-test probability of 2.0 / ( 2.0 + 1 ) = 66.7 % 2.0 / (2.0 + 1) = 66.7\% 2.0/ ( 2.0 + 1 ) = 66.7% .

Receiver Operating Characteristic (ROC) Curves

Many clinical tests yield continuous numerical results (e.g., troponin) requiring a cutoff threshold.

Shifting Cutoffs

Adjusting the cutoff threshold creates a trade-off between sensitivity and specificity:

Lowering the Cutoff: Increases sensitivity (more true positives are captured) but decreases specificity (more false positives are introduced).

Raising the Cutoff: Increases specificity (fewer false positives are generated) but decreases sensitivity (more true positives are missed).

The ROC Plot

An ROC curve plots Sensitivity (y-axis) against 1 - Specificity (x-axis).

Area Under the Curve (AUC): Measures the overall accuracy of the test.

AUC = 1.0 \text{AUC} = 1.0 AUC = 1.0 : A perfect test with no overlap between diseased and healthy populations.

AUC = 0.5 \text{AUC} = 0.5 AUC = 0.5 : A test with no diagnostic value, equivalent to a random guess.

The closer the curve clings to the top-left corner, the higher the diagnostic accuracy of the test.